Vasant Narasimhan

Chief Executive Officer at Novartis AG

Vasant Narasimhan

Vasant Narasimhan

Chief Executive Officer at Novartis AG

Overview
Career Highlights

Novartis Vaccines & Diagnostics, Inc.
Novartis International AG
Novartis AG

RelSci Relationships

2426

Number of Boards

8

Birthday

1976

Age

44

Relationships
RelSci Relationships are individuals Vasant Narasimhan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Hospira, Inc.

Relationship likelihood: Strong

Former Chief Operating Officer at Novartis Corporation

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

President at Novartis Institutes for BioMedical Research, Inc.

Relationship likelihood: Strong

Head of the Novartis Vaccines & Diagnostics Division at Novartis Corporation

Relationship likelihood: Strong

Industrial Partner for IT, Digital & Media, Healthcare & Pharma at Rantum Capital Management GmbH

Relationship likelihood: Strong

Former Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Former Group General Counsel at Novartis AG

Relationship likelihood: Strong

Paths to Vasant Narasimhan
Potential Connections via
Relationship Science
You
Vasant Narasimhan
Chief Executive Officer at Novartis AG
Memberships
Member
Current

The Institute of Medicine (IOM) is an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to decision makers and the public. Established in 1970, the IOM is the health arm of the National Academy of Sciences, which was chartered under President Abraham Lincoln in 1863. Nearly 150 years later, the National Academy of Sciences has expanded into what is collectively known as the National Academies, which comprises the National Academy of Sciences, the National Academy of Engineering, the National Research Council, and the IOM.

Member
Current

The participating CEOs lead companies that collectively employ more than five million people, generate more than $2 trillion in annual revenue, and represent 11 countries and a diverse group of industries.

Career History
Chief Executive Officer
2016 - Current

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Chief Executive Officer
2005 - Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Medical & Scientific Advisor
Tenure Unconfirmed

MPM invests in companies located in the US and across the globe. The firm focuses on companies that aim to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and health technology sector. They provide financing for early stage transactions.

Boards & Committees
Member, Executive Committee
Current
Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
2018 World Economic Forum Annual Meeting

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vasant Narasimhan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vasant Narasimhan's profile does not indicate a business or promotional relationship of any kind between RelSci and Vasant Narasimhan.